MedPath

The Generation R Study, Phase 3 - Focus at 9

Completed
Conditions
no specific disorder: growth and development
10010273
10037173
10024450
Registration Number
NL-OMON41521
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
29000
Inclusion Criteria

Pariticipation in Generation R Phase 3
Consent for participation in Generation R Phase 3

Exclusion Criteria

Temporary or fully withdrawn from participating in the Generation R Study
Death of the child

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The datacollection is divided into several outcomes:<br /><br>- asthma<br /><br>- bacterial carriage and infectious disease<br /><br>- bone density<br /><br>- cognition<br /><br>- ethnic and social-economic health inequalities<br /><br>- behaviour<br /><br>- growth, overweight and obesity<br /><br>- neural development<br /><br>- quality of life<br /><br>- body composition<br /><br>- stress reactivity<br /><br>- risk factors for cardiovasculair disease in children<br /><br>- risk factors for cardiovasculair disease in women<br /><br>- musculo-skeletale developement<br /><br>- circadian rhythm<br /><br>- physical activity<br /><br>- sleep</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable </p><br>
© Copyright 2025. All Rights Reserved by MedPath